36
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
964531
AdvantiGen Biosciences develops protein-based tools for research and pharmaceutical industries, focusing on improving human health.
- Mark Jackson: Co-FounderPast Role: Neoclone, Scientist & Co-Founder
- Mark Jackson: Chief Operating OfficerPast Role: Neoclone, Scientist & Co-Founder
About the Company
AdvantiGen Biosciences specializes in the development of protein-based tools and services for research, biotechnology, and pharmaceutical industries. The company focuses on creating innovative solutions to advance medical device development and drug discovery, aiming to improve human health. AdvantiGen Biosciences offers expertise in eukaryotic and
prokaryotic protein expression, protein purification, and quantification. The company holds proprietary technologies, including patented novel infrared fluorophores and processes for antibody and monobody development. AdvantiGen Biosciences collaborates with partners to develop antibodies for reagent, diagnostic, and therapeutic applications, leveraging its patented reactivation technology.
